Theonie Anastassiadis
Gründer bei Flagship Labs 89, Inc.
Aktive Positionen von Theonie Anastassiadis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Private-Equity-Analyst | - | - |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Gründer | - | - |
| Corporate Officer/Principal | - | - | |
| Flagship Labs 89, Inc. | Gründer | - | - |
| Präsident | - | - |
Karriereverlauf von Theonie Anastassiadis
Ausbildung von Theonie Anastassiadis
| Haverford College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Founder | 2 |
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Alltrna
Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius. | Health Technology |
| Flagship Labs 89, Inc. | Health Technology |
- Börse
- Insiders
- Theonie Anastassiadis
- Erfahrung
